Skip to main content

Cervical Adenosquamous Carcinoma clinical trials at UC Davis

1 research study open to eligible people

Showing trials for
  • Experimental Atezolizumab Before and/or With Chemoradiotherapy for Locally Advanced Cervical Cancer

    open to eligible females ages 18 years and up

    This phase I trial studies how well atezolizumab before and/or with standard of care chemoradiotherapy works in immune system activation in patients with stage IB2, II, IIIB, or IVA cervical cancer that has spread to the lymph nodes. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving atezolizumab before and/or with chemoradiotherapy may lower the chance of tumors growing or spreading.

    Sacramento, California and other locations